• Je něco špatně v tomto záznamu ?

Effectiveness of degradable polymer film in the management of severe or moderate intrauterine adhesions (PREG-2): a randomized, double-blind, multicenter, stratified, superiority trial

H. Fernandez, L. Miquel, J. Sroussi, S. Weyers, M. Munmany, X. Luo, P. Kovar, Y. Wang, B. Zizolfi, A. Surbone, V. Delporte, E. Moratalla, M. Sauvan, G. Perrini, L. Sui, M. Mara

. 2024 ; 122 (6) : 1124-1133. [pub] 20240722

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články, multicentrická studie, randomizované kontrolované studie

Perzistentní odkaz   https://www.medvik.cz/link/bmc25003315

OBJECTIVE: To study the effectiveness of a new intrauterine degradable polymer film (Womed Leaf) in the management of moderate to severe intrauterine adhesions (IUA). DESIGN: PREG-2 study was a multicenter, double-blind, randomized, controlled, stratified, two-arm superiority clinical trial conducted in 16 centers in seven countries. SETTING: Not applicable. PATIENT(S): Patients ≥18 years scheduled for hysteroscopic adhesiolysis because of symptomatic severe or moderate adhesions (according to American Fertility Society [AFS] IUA score) were considered eligible for the study. INTERVENTION(S): After adhesiolysis, patients were randomized at a 1:1 ratio to either have a Womed Leaf film inserted (intervention group) or not (control group). MAIN OUTCOME MEASURE(S): The primary effectiveness endpoint of the study was the change in AFS IUA score on second-look hysteroscopy (SLH), assessed by an independent evaluator, and compared with baseline. Information on the rate of no IUA and responder rate was collected as secondary effectiveness outcomes, while reported adverse events and patient-reported outcomes as safety and tolerability measures. RESULT(S): Between October 26, 2021, and September 28, 2023, a total of 160 women were randomized (Womed Leaf: n = 75 and controls: n = 85). The reduction in IUA AFS score on SLH was significantly higher in the intervention compared with the control group (mean 5.2 ± 2.8 vs. 4.2 ± 3.2). Similarly, the absence of adhesions on SLH was significantly higher in the intervention group (41% vs. 24%; odds ratio, 2.44; confidence interval, 1.161-5.116). None of the reported adverse events were serious or considered related to the device. CONCLUSION(S): Womed Leaf is effective and safe in the management of symptomatic severe or moderate IUAs. CLINICAL TRIAL REGISTRATION NUMBER: Clinicaltrials.gov identifier: NCT04963179.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc25003315
003      
CZ-PrNML
005      
20250206104242.0
007      
ta
008      
250121s2024 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.fertnstert.2024.07.020 $2 doi
035    __
$a (PubMed)39048019
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Fernandez, Hervé $u Department of Gynecology and Obstetrics, Université Paris-Saclay, Paris, France. Electronic address: hervefernandez@orange.fr
245    10
$a Effectiveness of degradable polymer film in the management of severe or moderate intrauterine adhesions (PREG-2): a randomized, double-blind, multicenter, stratified, superiority trial / $c H. Fernandez, L. Miquel, J. Sroussi, S. Weyers, M. Munmany, X. Luo, P. Kovar, Y. Wang, B. Zizolfi, A. Surbone, V. Delporte, E. Moratalla, M. Sauvan, G. Perrini, L. Sui, M. Mara
520    9_
$a OBJECTIVE: To study the effectiveness of a new intrauterine degradable polymer film (Womed Leaf) in the management of moderate to severe intrauterine adhesions (IUA). DESIGN: PREG-2 study was a multicenter, double-blind, randomized, controlled, stratified, two-arm superiority clinical trial conducted in 16 centers in seven countries. SETTING: Not applicable. PATIENT(S): Patients ≥18 years scheduled for hysteroscopic adhesiolysis because of symptomatic severe or moderate adhesions (according to American Fertility Society [AFS] IUA score) were considered eligible for the study. INTERVENTION(S): After adhesiolysis, patients were randomized at a 1:1 ratio to either have a Womed Leaf film inserted (intervention group) or not (control group). MAIN OUTCOME MEASURE(S): The primary effectiveness endpoint of the study was the change in AFS IUA score on second-look hysteroscopy (SLH), assessed by an independent evaluator, and compared with baseline. Information on the rate of no IUA and responder rate was collected as secondary effectiveness outcomes, while reported adverse events and patient-reported outcomes as safety and tolerability measures. RESULT(S): Between October 26, 2021, and September 28, 2023, a total of 160 women were randomized (Womed Leaf: n = 75 and controls: n = 85). The reduction in IUA AFS score on SLH was significantly higher in the intervention compared with the control group (mean 5.2 ± 2.8 vs. 4.2 ± 3.2). Similarly, the absence of adhesions on SLH was significantly higher in the intervention group (41% vs. 24%; odds ratio, 2.44; confidence interval, 1.161-5.116). None of the reported adverse events were serious or considered related to the device. CONCLUSION(S): Womed Leaf is effective and safe in the management of symptomatic severe or moderate IUAs. CLINICAL TRIAL REGISTRATION NUMBER: Clinicaltrials.gov identifier: NCT04963179.
650    _2
$a dospělí $7 D000328
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a vstřebatelné implantáty $7 D020341
650    _2
$a dvojitá slepá metoda $7 D004311
650    12
$a hysteroskopie $x metody $x škodlivé účinky $7 D015907
650    _2
$a polymery $7 D011108
650    _2
$a stupeň závažnosti nemoci $7 D012720
650    _2
$a adheze tkání $7 D000267
650    _2
$a výsledek terapie $7 D016896
650    12
$a nemoci dělohy $x diagnóza $7 D014591
655    _2
$a časopisecké články $7 D016428
655    _2
$a multicentrická studie $7 D016448
655    _2
$a randomizované kontrolované studie $7 D016449
700    1_
$a Miquel, Laura $u Department of Gynecology and Obstetrics, Assistance Publique-Hôpitaux de Marseille (AP-HM), Marseille, France
700    1_
$a Sroussi, Jérémy $u Department of Obstetrics and Gynecology, Lariboisière Hospital, Public Assistance Hospitals of Paris, Paris, France
700    1_
$a Weyers, Steven $u Department of Obstetrics and Gynaecology, Ghent University Hospital, Ghent, Belgium
700    1_
$a Munmany, Meritxell $u Department of Obstetrics and Gynaecology, Hospital Clínic Barcelona, Barcelona, Spain
700    1_
$a Luo, Xiping $u Guangdong Maternal and Child Health Hospital, Panyu District, Guangzhou, People's Republic of China
700    1_
$a Kovar, Petr $u Ordinace Gynenatal, Baska, Czechia
700    1_
$a Wang, Yue $u Department of Obstetrics and Gynaecology, Women's Hospital School of Medicine, Zhejiang University, People's Republic of China
700    1_
$a Zizolfi, Brunella $u Department of Public Health, University of Naples Federico II, Naples, Italy
700    1_
$a Surbone, Anna $u Department of Obstetrics and Gynaecology, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland
700    1_
$a Delporte, Victoire $u Department of Gynecologic Surgery, Jeanne de Flandre Hospital, Centre Hospitalier Universitaire de Lille, Loos, Lille, France
700    1_
$a Moratalla, Enrique $u Department of Obstetrics and Gynaecology, Ramón y Cajal Hospital, Madrid, Spain
700    1_
$a Sauvan, Marine $u Department of Obstetrics and Gynaecology, Clinique Mutualiste La Sagesse, Rennes, France
700    1_
$a Perrini, Gaetano $u Department of Obstetrics and Gynaecology, Hôpital Umberto I Mauriziano de Torino, Torino, Italy
700    1_
$a Sui, Long $u Obstetrics & Gynecology Hospital Affiliated to Fudan University, Shanghai, People's Republic of China
700    1_
$a Mara, Michal $u Department of Gynecology Obstetrics and Neonatology, General Faculty Hospital and 1st Faculty of Medicine in Prague, Prague, Czechia
773    0_
$w MED00001795 $t Fertility and sterility $x 1556-5653 $g Roč. 122, č. 6 (2024), s. 1124-1133
856    41
$u https://pubmed.ncbi.nlm.nih.gov/39048019 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20250121 $b ABA008
991    __
$a 20250206104237 $b ABA008
999    __
$a ok $b bmc $g 2263212 $s 1239322
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2024 $b 122 $c 6 $d 1124-1133 $e 20240722 $i 1556-5653 $m Fertility and sterility $n Fertil Steril $x MED00001795
LZP    __
$a Pubmed-20250121

Najít záznam

Citační ukazatele

Možnosti archivace